Search in:

ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue

Submit an article Journal homepage

Open access

121

Views

CrossRef citations to date

Altmetric

Original Research

Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan

Kaoru Yamabe1 Healthcare Policy and Access, Takeda Pharmaceutical Company Limited, Nihonbashi, Chuouku, Tokyo 103-8668, Japan, [email protected]Correspondence[email protected]

Ryan Liebert2 Health Outcomes Research, Kantar Health, New York, NY 10010, USA

Natalia Flores2 Health Outcomes Research, Kantar Health, New York, NY 10010, USA

Chris L Pashos3 Global Outcomes and Epidemiology Research, Data Sciences Institute, Takeda Pharmaceuticals International Inc., Cambridge, MA, 02139, USA

Pages 221-232 | Published online: 12 Mar 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Laura Targownik, Marla C Dubinsky, Flavio Steinwurz, Andrew G Bushmakin, Joseph C Cappelleri, Elaine Tai, Sean Gardiner, Peter Hur & Julian Panés. (2023) Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain. Journal of Crohn's and Colitis 17:4, pages 513-523.
Crossref

Xiaojing Wang, Shaowei Huang, Meiling Zhang, Yulin Su, Zengfeng Pan, Junjie Liang, Xueqian Xie, Qing Wang, Jinyan Chen, Lian Zhou & Xia Luo. (2023) Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice. Journal of Ethnopharmacology 302, pages 115919.
Crossref

Weiwei Dai, Yufeng Zeng, E. Liang, Qiuhong Zhou, Lei Zhang & Jie Peng. (2021) The actuality of resilience, social support and quality of life among patients with inflammatory bowel disease in China. Nursing Open 9:4, pages 2190-2198.
Crossref

Elizabeth Dent, Nicola Davinson & Stephanie Wilkie. (2021) The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Applied Psychology: Health and Well-Being 14:2, pages 626-644.
Crossref

Kasenee Tiankanon, Julajak Limsrivilai, Napapat Poocharoenwanich, Phutthaphorn Phaophu, Nichcha Subdee, Natanong Kongtub & Satimai Aniwan. (2021) Burden of Inflammatory Bowel Disease on Patient Mood, Fatigue, Work, and Health-Related Quality of Life in Thailand: A Case-Control Study. Crohn's & Colitis 360 3:4.
Crossref

Reinier Cornelis Anthonius Linschoten, Elyke Visser, Christa Diana Niehot, C. Janneke Woude, Jan Antonius Hazelzet, Desirée Noord & Rachel Louise West. (2021) Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents. Alimentary Pharmacology & Therapeutics 54:3, pages 234-248.
Crossref

Celine Miyazaki, Nagano Katsumasa, Kuan Chih Huang & Yan Fang Liu. (2021) Evaluation of economic burden with biologic treatments in Crohn’s disease patients: A mirror image study using an insurance database in Japan. PLOS ONE 16:7, pages e0254807.
Crossref

Liang Chen, Chun Jin Xu, Wei Wu, Bai Jing Ding & Zhan Ju Liu. (2021) Anti‐TNF and immunosuppressive combination therapy is preferential to inducing clinical remission in patients with active inflammatory bowel disease: A systemic review and meta‐analysis . Journal of Digestive Diseases 22:7, pages 408-418.
Crossref

Marcela Guevara, Elena Salamanca-Fernández, Estrella Miqueleiz, Diana Gavrila, Pilar Amiano, Catalina Bonet, Miguel Rodríguez-Barranco, José María Huerta, Luis Bujanda, María José Sánchez, María Dolores Chirlaque, Antonio Agudo, Eva Ardanaz & Jesús Castilla. (2021) Inflammatory Potential of the Diet and Incidence of Crohn’s Disease and Ulcerative Colitis in the EPIC-Spain Cohort. Nutrients 13:7, pages 2201.
Crossref

Afifah Zahra Agista, Tubagus Bahtiar Rusbana, Jahidul Islam, Yusuke Ohsaki, Halima Sultana, Ryota Hirakawa, Kouichi Watanabe, Tomonori Nochi, Ardiansyah, Slamet Budijanto, Suh-Ching Yang, Takuya Koseki, Hisashi Aso, Michio Komai & Hitoshi Shirakawa. (2021) Fermented Rice Bran Supplementation Prevents the Development of Intestinal Fibrosis Due to DSS-Induced Inflammation in Mice. Nutrients 13:6, pages 1869.
Crossref

Celine Miyazaki, Takuya Sakashita, Wonjoo Jung & Shingo Kato. (2021) Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis. Advances in Therapy 38:5, pages 2229-2247.
Crossref

Huyen Thi Thanh Tran, Shota Saito, Shinichi Noto & Kenji Suzuki. (2020) Quality of Life and Eligibility for Specific Financial Assistance for Medical Expenses: A Cross-Sectional Web-Based Survey among Patients with Inflammatory Bowel Disease in Japan. Gastrointestinal Disorders 2:2, pages 123-133.
Crossref

Zili Lin, Huiyi Wu, Yiming Fu & Shixue Dai. (2019) Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy. Inflammatory Bowel Diseases 25:12, pages 1886-1895.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date